Clinical study on Evaluation of siddha trial drug Aavarai karukku kudineer for neerkana mantham (acute nasopharyngitis)

PHASE II NON RANDOMIZED CLINICAL STUDY ON NEER KANA MANTHAM(ACUTE NASOPHARYNGITIS) WITH EVALUATION OF SIDDHA TRIAL DRUG AAVARAI KARUKKU KUDINEER

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029191

Enrollment

Registered

2020-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: AAVARAI KARUKKU KUDINEER: 30 ml of decoction is administrated once a day for 7 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Running Nose Fever Cough Malaise Loss of Appetite head ache

Exclusion criteria

Exclusion criteria: Allergic Rhinitis Bronchitis Bronchial Asthma Sever diarrhea with other complication

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptomsTimepoint: 7 days	—

Secondary

Measure	Time frame
comparing safety parameters before and after treatmentTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Manju S

Government Siddha Medical College Chennai

ranimoorthybsms19@gmail.com9442286863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026